Alirocumab
LPS14354
Approved small_molecule completed
Quick answer
Alirocumab for Dyslipidemia is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Dyslipidemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed